This Week in Nature

In Nature this week, researchers from Baylor College of Medicine report on the discovery of potential targets for the neurodegenerative disease spinocerebellar ataxia type 1, or SCA1, through the use of a novel strategy of genetic network screening. Noting that the severity of SCA1 is associated with the accumulation of mutant ataxin 1 protein, the team used cross-species genetic screening to identify druggable targets that modulate levels of this protein.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.